Target intelligence / Profile preview

Gardnerella vaginalis biofilm formation (G. vaginalis biofilm)

Target
G. vaginalis biofilm
Molecular classification
Other, Microbial virulence factor
01

Overview

Gardnerella vaginalis biofilm formation is a complex multicellular process that serves as the primary virulence mechanism in bacterial vaginosis (BV). The process begins with the adhesion of G. vaginalis to vaginal epithelial cells, facilitated by various adhesins and the toxin vaginolysin, leading to the formation of characteristic clue cells (Swidsinski et al., 2005). Once established, the biofilm produces an extracellular polymeric substance (EPS) matrix that provides a physical barrier against host immune defenses and increases the minimum inhibitory concentration (MIC) of antibiotics by up to 1000-fold compared to planktonic cells (Machado et al., 2016). This structural integrity is a major cause of treatment failure and high recurrence rates associated with standard therapies like metronidazole. Current research focuses on multi-modal approaches, including biofilm-disrupting agents like boric acid or DNase, and the use of probiotics to restore a healthy vaginal microbiome (Muzny et al., 2019). Targeting the biofilm is essential for achieving long-term clinical cure and preventing complications such as preterm birth and increased susceptibility to sexually transmitted infections (Alves et al., 2014).

Other names
Bacterial vaginosis biofilmVaginal biofilmG. vaginalis adherent biofilm
02

Mechanism of action

Inhibition of bacterial adhesion to vaginal epithelial cells, degradation of the extracellular polymeric substance (EPS) matrix, or disruption of quorum sensing and metabolic activity within the established biofilm structure.

03

Biological functions

Bacterial adhesionExtracellular matrix productionAntibiotic resistanceImmune evasionOther
04

Disease associations

InfectionBacterial vaginosisPreterm birthPelvic inflammatory diseaseOther
05

Safety considerations

Vaginal dysbiosis (disruption of commensal Lactobacillus species)High rates of clinical recurrence due to incomplete biofilm eradicationPotential for antibiotic resistance development
06

Interacting drugs

Metronidazole

7 more in the full profile.

07

Biomarkers

Clue cellsVaginal pH > 4.5Sialidase activityNugent scoreGardnerella vaginalis load (qPCR)

Beyond the preview

Go deeper on Gardnerella vaginalis biofilm formation (G. vaginalis biofilm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gardnerella vaginalis biofilm formation (G. vaginalis biofilm).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call